<?xml version="1.0" encoding="UTF-8"?>
<p>In recent years, the treatment paradigm for AD is moving toward alleviating the inflammation associated with the development of this disease [
 <xref rid="B163-biomolecules-11-00350" ref-type="bibr">163</xref>,
 <xref rid="B164-biomolecules-11-00350" ref-type="bibr">164</xref>]. Hence, the exploration of novel sesquiterpenes for the expression of NF-κβp65 could be a target for scientists for the management of neurodegenerative disorderssuch asAD.
</p>
